ICICI Prudential Asset Management Co Ltd Has $9.72 Million Stake in Agilent Technologies, Inc. $A

ICICI Prudential Asset Management Co Ltd boosted its position in shares of Agilent Technologies, Inc. (NYSE:A) by 8.9% during the 3rd quarter, HoldingsChannel reports. The firm owned 75,728 shares of the medical research company’s stock after buying an additional 6,200 shares during the quarter. Agilent Technologies accounts for 1.0% of ICICI Prudential Asset Management Co Ltd’s investment portfolio, making the stock its 17th biggest holding. ICICI Prudential Asset Management Co Ltd’s holdings in Agilent Technologies were worth $9,720,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Norges Bank acquired a new stake in shares of Agilent Technologies in the second quarter worth $395,088,000. AQR Capital Management LLC lifted its stake in Agilent Technologies by 424.1% in the 2nd quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock worth $240,956,000 after acquiring an additional 1,652,244 shares in the last quarter. Ameriprise Financial Inc. boosted its position in Agilent Technologies by 132.2% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock worth $277,807,000 after acquiring an additional 1,340,161 shares during the period. Massachusetts Financial Services Co. MA grew its stake in Agilent Technologies by 10.7% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 13,227,387 shares of the medical research company’s stock valued at $1,560,964,000 after acquiring an additional 1,273,994 shares in the last quarter. Finally, Troy Asset Management Ltd increased its holdings in shares of Agilent Technologies by 74.3% in the 2nd quarter. Troy Asset Management Ltd now owns 2,397,820 shares of the medical research company’s stock valued at $282,967,000 after purchasing an additional 1,021,865 shares during the period.

Agilent Technologies Price Performance

NYSE A opened at $126.15 on Friday. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $160.27. The stock’s 50-day moving average is $136.50 and its two-hundred day moving average is $135.55. The firm has a market cap of $35.68 billion, a P/E ratio of 27.60, a price-to-earnings-growth ratio of 3.69 and a beta of 1.30. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.96 and a quick ratio of 1.52.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Monday, November 24th. The medical research company reported $1.59 EPS for the quarter, beating analysts’ consensus estimates of $1.58 by $0.01. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.The business had revenue of $1.86 billion for the quarter, compared to analyst estimates of $1.83 billion. During the same quarter in the prior year, the firm posted $1.46 EPS. The firm’s revenue for the quarter was up 9.4% on a year-over-year basis. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. On average, analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 22nd. Stockholders of record on Tuesday, March 31st will be paid a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Tuesday, March 31st. Agilent Technologies’s payout ratio is presently 22.32%.

Insider Buying and Selling at Agilent Technologies

In related news, VP Rodney Gonsalves sold 3,000 shares of the company’s stock in a transaction on Wednesday, November 26th. The shares were sold at an average price of $154.99, for a total transaction of $464,970.00. Following the completion of the sale, the vice president directly owned 31,846 shares of the company’s stock, valued at approximately $4,935,811.54. This represents a 8.61% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on A. Citigroup boosted their price objective on shares of Agilent Technologies from $165.00 to $185.00 and gave the company a “buy” rating in a research report on Tuesday, November 25th. HSBC began coverage on shares of Agilent Technologies in a report on Tuesday, January 20th. They set a “buy” rating and a $180.00 price target on the stock. Wells Fargo & Company upped their price target on shares of Agilent Technologies from $150.00 to $175.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 25th. Robert W. Baird lifted their price objective on Agilent Technologies from $142.00 to $165.00 and gave the company an “outperform” rating in a research report on Tuesday, November 25th. Finally, Morgan Stanley began coverage on Agilent Technologies in a research note on Tuesday, December 2nd. They issued an “overweight” rating on the stock. Two analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, Agilent Technologies presently has a consensus rating of “Moderate Buy” and an average price target of $164.50.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.